STOCK TITAN

nLIGHT (NASDAQ: LASR) CEO details option exercise, Rule 10b5-1 sales

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4/A

Rhea-AI Filing Summary

nLIGHT, Inc. President and CEO, who is also a director, filed an amended insider trading report detailing an option exercise and related share sales in the company’s common stock on 01/06/2026. The filing shows the exercise of a stock option for 31,748 shares at an exercise price of $1.10 per share, followed by open-market sales of 10,902, 18,028, and 2,818 shares at weighted average prices of $36.74, $37.84, and $38.33, respectively. The sales were made under a Rule 10b5-1 trading plan adopted on June 12, 2025. After these transactions, the reporting person beneficially owns 2,285,020 shares directly and 4,474 shares indirectly through the Keeney Family Revocable Trust. The amendment updates exercise prices, grouped sale price ranges, vesting and expiration details, and adds the trust holdings.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Keeney Scott H

(Last) (First) (Middle)
4637 NW 18TH AVENUE

(Street)
CAMAS WA 98607

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
NLIGHT, INC. [ LASR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President and CEO
3. Date of Earliest Transaction (Month/Day/Year)
01/06/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
01/09/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 01/06/2026 M 31,748 A $1.1 2,316,768(1) D
Common Stock 01/06/2026 S 10,902 D(2) $36.74(3) 2,305,866(1) D
Common Stock 01/06/2026 S 18,028 D(2) $37.84(4) 2,287,838(1) D
Common Stock 01/06/2026 S 2,818 D(2) $38.33(5) 2,285,020(1) D
Common Stock 4,474 I By Keeney Family Revocable Trust(6)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $1.1 01/06/2026 M 0 (7) 07/01/2026 Common Stock 31,748 $0 0 D
Explanation of Responses:
1. Includes common stock owned and unvested restricted stock units.
2. This reported sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025.
3. The reported transaction involves sale transactions from $36.27 to $37.27 per share. The weighted average price per share was $36.74. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price.
4. The reported transaction involves sale transactions from $37.27 to $38.27 per share. The weighted average price per share was $37.84. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price.
5. The reported transaction involves sale transactions from $38.27 to $38.49 per share. The weighted average price per share was $38.33. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price.
6. Keeney Family Revocable Trust is a revocable living trust for which the reporting person and his spouse are trustees
7. This grant became fully vested and exercisable on October 1, 2019.
Remarks:
This Form 4 was amended for the below items: Included indirect holdings by Keeney Family Revocable Trust to Table I; Corrected exercise price of shares acquired in Table I; Updated share sale transactions in Table I to group transactions within a $1 sale price, and included Footnotes 3 - 5; Updated date award was fully vested and exercisable in Footnote 7; Corrected exercise price and expiration date of derivative securities exercised in Table II.
/s/ Julie Dimmick, as attorney-in-fact 01/14/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did nLIGHT (LASR) report in this Form 4/A?

The report shows the President and CEO exercised a stock option for 31,748 shares at $1.10 per share and sold 10,902, 18,028, and 2,818 common shares at weighted average prices of $36.74, $37.84, and $38.33, respectively.

Were the nLIGHT (LASR) share sales under a Rule 10b5-1 trading plan?

Yes. The filing states the reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025.

How many nLIGHT (LASR) shares does the insider own after these transactions?

After the reported transactions, the insider beneficially owns 2,285,020 common shares directly and 4,474 shares indirectly through the Keeney Family Revocable Trust.

What option grant did the nLIGHT (LASR) CEO exercise in this filing?

The CEO exercised a stock option covering 31,748 shares of common stock at an exercise price of $1.10 per share. The grant became fully vested and exercisable on October 1, 2019 and carries an expiration date of July 1, 2026.

Why was this nLIGHT (LASR) Form 4 amended?

The amendment adds indirect holdings by the Keeney Family Revocable Trust to Table I, corrects exercise prices, groups sale transactions within $1 price ranges with added footnotes, updates the vesting date in Footnote 7, and corrects the exercise price and expiration date for the derivative securities in Table II.

What price ranges were involved in the nLIGHT (LASR) share sales?

Footnotes state the sales occurred in ranges of $36.27–$37.27, $37.27–$38.27, and $38.27–$38.49 per share, with weighted average prices of $36.74, $37.84, and $38.33, respectively.
Nlight

NASDAQ:LASR

LASR Rankings

LASR Latest News

LASR Latest SEC Filings

LASR Stock Data

2.32B
47.24M
6.33%
86.57%
3.29%
Semiconductors
Semiconductors & Related Devices
Link
United States
CAMAS